Classification | Sub-classification | IMeRSe (total n = 625#) n | PharMIbridge (total n = 170) n |
---|---|---|---|
Drug selection | D0 Other drug selection problem | 41 | 18 |
D1 Duplication | 7 | 0 | |
D2 Drug interaction | 12 | 0 | |
D3 Wrong drug | 2 | 2 | |
D4 Incorrect strength | 1 | 1 | |
D5 Inappropriate dosage form | 3 | 0 | |
D6 Contraindications apparent | 8 | 2 | |
D7 No indication apparent | 8 | 1 | |
Subtotal n (%) | 81 (13.1) | 24 (14.1) | |
Over or underdose | O0 Other dose problem | 21 | 4 |
O1 Prescribed dose too high | 12 | 7 | |
O2 Prescribed dose too low | 11 | 3 | |
O3 Incorrect or unclear dosing instructions | 6 | 1 | |
Subtotal n (%) | 50 (8.0) | 15 (8.8) | |
Compliance | C0 Other compliance problem | 47 | 6 |
C1 Under-use by consumer | 60 | 12 | |
C2 Over-use by consumer | 5 | 1 | |
C3 Erratic use of medication | 23 | 6 | |
C4 Intentional drug misuse (incl. over-the-counter medications) | 3 | 0 | |
C5 Difficulty using dosage form | 19 | 0 | |
Subtotal n (%) | 157 (25.1) | 25 (14.7) | |
Undertreated | U0 Other undertreated indication problem | 19 | 1 |
U1 Condition undertreated | 65 | 13 | |
U2 Condition untreated | 35 | 3 | |
U3 Preventative therapy required | 20 | 1 | |
Subtotal n (%) | 139 (22.2) | 18 (10.6) | |
Monitoring | M0 Other monitoring problem | 6 | 5 |
M1 Laboratory monitoring | 45 | 5 | |
M2 Non-laboratory monitoring | 26 | 11 | |
Subtotal n (%) | 77 (12.3) | 21 (12.4) | |
Education or information | E0 Other education or information problem | 36 | 7 |
E1 Patient requests drug information | 10 | 4 | |
E2 Patient requests disease management advice | 6 | 3 | |
Subtotal n (%) | 52 (8.3) | 14 (8.2) | |
Not classifiable | N0 Clinical interventions that cannot be classified | 36 | 12 |
Subtotal n (%) | 36 (5.8) | 12 (7.1) | |
Toxicity or adverse reaction | T1 Toxicity, allergic reaction or adverse effect | 32 (5.1) | 41 (24.1) |
Subtotal n (%) | 32 (5.1) | 41 (24.1) |